Nav: Home

Global Rheumatoid Arthritis diagnosis test market expected to reach US$ 1,002.0 mn in 2027

February 11, 2018

Persistence Market Research has come up with revised forecasts on the global rheumatoid arthritis diagnosis test market. According to this latest market report titled 'Rheumatoid Arthritis Diagnosis Test Market: Global Industry Analysis (2012-2016) and Forecast (2017-2027)', the global market is expected to expand at a CAGR of 6.3% during the forecast period 2017-2027. The global market is estimated to reach a valuation of more than US$ 1 Bn by the end of the year of assessment from a value of about US$ 545 Mn in 2017.

Request to sample report https://www.persistencemarketresearch.com/samples/4788

The market is segmented based on test type, end user and region. On the basis of test type, the market has been segmented into two segments such as serology tests and monitoring RA treatment efficiency tests. The serology tests segment is further divided into six sub-segments are-erythrocyte sedimentation rate (ESR), rheumatoid factor (RF), anti-cyclic citrullinated peptide (anti-CCP), antinuclear antibody (ANA), uric acid and other tests. The monitoring RA treatment efficiency tests segment is also further divided into salicylate level count, muscle enzyme tests (CPK, Aldolase) and creatinine test. Serology tests segment is expected to be the fastest growing segment over the forecast period, registering the significant CAGR of 6.5% over the forecast period. Increasing incidence of autoimmune diseases, off-label prescription of NSAIDs and other pain management drugs are projected to increase demand for RA diagnosis. Commercialization of rapid diagnostic test, especially in anti-CCP test would provide key growth opportunities for RA test kits manufacturers.

However, higher costs of these test kits and limited sensitivity when performed as individual test are major restraining factors for this market. Revenue contribution from serology segment, the anti-CCP test segment has been estimated to be the highest, accounting for 31.1% of the total rheumatoid arthritis market share in 2016 and is expected to be one of the most lucrative segments over the forecast period. Limited sensitivity of other tests such as ANA antibody and RF test provide competitive advantage over anti-CCP test. However, availability of these tests at remote location of Asia Pacific region is a major challenge for the market.

On the basis of end user, the market has been segmented into diagnostics laboratories, ambulatory surgical centers and hospitals. Ambulatory surgical centers segment is projected to be the fastest-growing segment, registering a 6.6% value CAGR in terms of revenue.

On the basis of region, the rheumatoid arthritis diagnosis tests market is segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Europe and Asia Pacific regions have been estimated to collectively account for around 60% revenue share in 2016, owing to higher adoption of RA diagnosis test and increasing prevalence rate of autoimmune diseases. However, high RA prevalent region (North America) tend to become saturated in terms of revenue generation, owing to increasing awareness and healthcare spending for RA treatment and monitoring.

The report begins with an overview of the rheumatoid arthritis diagnosis tests market in terms of value, and a detailed analysis of key trends, drivers and restraints, and opportunities, which are the main factors impelling growth of the rheumatoid arthritis test market. Impact analysis of key growth drivers and restraints based on the weighted average of each of these factors in a model-based approach is included in the report. The report provides in-depth information on potential scope of high-end confirmatory testing kits to provide clients with crystal clear decision-making insights.
-end-
Request Report for TOC @ https://www.persistencemarketresearch.com/market-research/rheumatoid-arthritis-market/toc

Key players operating in the rheumatoid arthritis diagnosis tests market include Abbott Diagnostics (Abbott Laboratories), Antibodies Inc., Beckman Coulter, Inc., Euro Diagnostica AB, F. Hoffmann-La Roche Ltd., Qiagen NV, Siemens Healthcare GmbH, and Thermo Fisher Scientific Inc., Bio Rad Laboratories Inc. and Genway Biotech, Inc. (Aviva Systems Biology Corp.).

These companies are focusing on commercialization of cost-effective, highly-sensitive and rapid test kits. However, there is stiff competition from local manufacturers owing to low entry barriers and limited awareness about RA test efficiency among physicians.

Get full Report Now @ https://www.persistencemarketresearch.com/checkout/4788

Health Affairs

Related Autoimmune Diseases Articles:

Cellular stress increases the probability of developing autoimmune diseases
Researchers found that cellular stress enhances the activation of certain type of immune cells with implications in many chronic inflammatory conditions.
Smoking decreases MAIT cells, implicated in the pathology of autoimmune diseases
New research published in the May 2017 issue of the Journal of Leukocyte Biology provides another reason why smoking tobacco is harmful.
Researchers describe ultrasensitive detection of protein linked to multiple autoimmune diseases
Researchers in France have developed a new method that will allow doctors to detect minute amounts of a protein called interferon- in patient samples.
Synthetic carbohydrates against autoimmune diseases
Researchers are developing an innovative approach for the treatment of a rare autoimmune disease of the peripheral nervous system, using a type of molecular sponge consisting of carbohydrates to remove pathogenic antibodies from the bloodstream.
Cargo-carrying red blood cells alleviate autoimmune diseases in mice
Using red blood cells modified to carry disease-specific antigens, a team of scientists from Whitehead Institute and Boston Children's Hospital have prevented and alleviated two autoimmune diseases -- multiple sclerosis (MS) and type 1 diabetes --i n early stage mouse models.
Study of complex genetic region finds hidden role of NCF1 in multiple autoimmune diseases
Medical University of South Carolina investigators report pre-clinical research showing that a genetic variant encoded in neutrophil cystolic factor 1 (NCF1) is associated with increased risk for autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, and Sjögren's syndrome, in the January 2017 issue of Nature Genetics.
'Master regulator' in genes may make women more susceptible to autoimmune diseases
New research identifies an inflammatory pathway in women that could help explain why they develop autoimmune diseases at a much higher rate than men.
Thwarting autoimmune diseases
The immunoproteasome dismantles proteins and the resulting fragments are displayed on the surface of cells.
HPV vaccine found safe in girls and women with autoimmune diseases
In a recent study of girls and women diagnosed with at least one autoimmune disease, vaccination against human papillomavirus (HPV) did not increase the risk of developing another autoimmune disease.
Cancer drugs could target autoimmune diseases
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King's College London.

Related Autoimmune Diseases Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Bias And Perception
How does bias distort our thinking, our listening, our beliefs... and even our search results? How can we fight it? This hour, TED speakers explore ideas about the unconscious biases that shape us. Guests include writer and broadcaster Yassmin Abdel-Magied, climatologist J. Marshall Shepherd, journalist Andreas Ekström, and experimental psychologist Tony Salvador.
Now Playing: Science for the People

#513 Dinosaur Tails
This week: dinosaurs! We're discussing dinosaur tails, bipedalism, paleontology public outreach, dinosaur MOOCs, and other neat dinosaur related things with Dr. Scott Persons from the University of Alberta, who is also the author of the book "Dinosaurs of the Alberta Badlands".